BCAB CIK: 1826892

BioAtla, Inc.

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
0.25
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−96.4
FY22:
−108
FY23:
−130
FY24:
−73.9
FY25:
−59.3
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−107
FY23:
−128
FY24:
−73.8
FY25:
−59.2
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−106
FY23:
−123
FY24:
−69.8
FY25:
−59.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−95.4
FY22:
−106
FY23:
−123
FY24:
−69.8
FY25:
−59.6

All amounts in millions USD Data sources:SEC EDGARTwelve Data